Table 3.: Summary of Adverse Events

FSC MDI (N =121) FSC DISKUS (N = 126)
AE’s occurring in >2% of patients in any group during treatment, n (%) 54 (45) 59 (47)
Any event 54 (45) 59 (47)
Headache 10 (8) 8 (6)
Nasopharyngtis 5 (4) 8 (6)
Cough 4 (3) 5 (4)
Sinusitis 3 (2) 6 (5)
Oropharyngeal pain 5 (4) 2 (2)
Other AE’s of interest, n (%)
 Pneumonia 0 2 (2)
 Eye disorders 0 0
 Bone disorders†† 1 (<1) 1 (<1)
 Death 0 0

Cataracts and glaucoma.
†† Foot fracture.